Showing results (41-50 of 560) with videos related to
Sort By:
Pageof 56
European Journal of Cancer (Oxford, England : 1990)|September 23, 2019
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trialsMichael Davidson, Anna Dorothea Wagner, Kyriakos Kouvelakis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies GroupNaureen Starling, Sheela Rao, David Cunningham, et al.Cancer Treatment Reviews|November 6, 2022
Advances in immunotherapy for MMR proficient colorectal cancerHazel Lote, Naureen Starling, Rille Pihlak, et al.Cancers|October 27, 2022
The Role of ctDNA in Gastric CancerJustin Mencel, Susanna Slater, Elizabeth Cartwright, et al.Clinical Colorectal Cancer|November 4, 2015
Current and Future Therapies for Advanced Gastric CancerMichael Davidson, Alicia F C Okines, Naureen StarlingBMC Cancer|January 22, 2015
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experienceKhurum Khan, Clare Peckitt, Francesco Sclafani, et al.Current Oncology (Toronto, Ont.)|September 26, 2025
Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary CentreJulia Freckelton, Justin Mencel, Iris Levink, et al.British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.Oncotargets and Therapy|October 14, 2022
Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical DevelopmentsAnderley Gordon, Edwina Johnston, David K Lau, et al.Pageof 56